Symposium: Future directions of cytokine and immunoglobulin therapy. Tucson, Arizona, January 11-12, 1991.
出版信息
Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S1-97.
PMID:1345898
Abstract
摘要
相似文献
1
Symposium: Future directions of cytokine and immunoglobulin therapy. Tucson, Arizona, January 11-12, 1991.
Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S1-97.
2
Clinical use of intravenous immunoglobulins.
Vox Sang. 2000;78 Suppl 2:191-5.
3
New peptide and protein drugs.
Pharm World Sci. 1996 Jun;18(3):87-93. doi: 10.1007/BF00417755.
4
[Immunotherapy in non-allergic diseases].
Allergol Immunopathol (Madr). 2000 May-Jun;28(3):107-9.
5
Immune biological products: normal and specific immunoglobulin.
Ann Ig. 1994 Jan-Feb;6(1):3-12.
6
Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
Pediatr Neurol. 2008 Sep;39(3):213-7. doi: 10.1016/j.pediatrneurol.2008.05.015.
7
Rituximab for pemphigus vulgaris.
N Engl J Med. 2007 Feb 1;356(5):521; author reply 521-2. doi: 10.1056/NEJMc063290.
8
Desensitization during renal transplantation.
N Engl J Med. 2008 Oct 16;359(16):1731; author reply 1731-2. doi: 10.1056/NEJMc081723.
9
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
J Pediatr. 2011 Apr;158(4):644-649.e1. doi: 10.1016/j.jpeds.2010.10.012. Epub 2010 Dec 3.
10
Third Interdisciplinary Symposium on the Treatment of Autoimmune Disorders, 8-10 June 2002, Leipzig, Germany.
Isr Med Assoc J. 2002 Nov;4(11 Suppl):973-6.
Zotero 插件